Neogen Q3 FY26 net loss widens to $17 million; revenue drops 4.4% to $211.2 million

Reuters04-09
Neogen Q3 FY26 net loss widens to $17 million; revenue drops 4.4% to $211.2 million
  • Neogen posted a fiscal third-quarter net loss of $17 million, widening from year-ago levels; diluted loss per share was $0.08.
  • Revenue fell 4.4% to $211.2 million, reflecting a 20.1% drop in Animal Safety sales to $54.5 million on third-party supplier issues.
  • Adjusted EBITDA edged down to $48.2 million from year-ago levels, while Food Safety revenue rose 2.6% to $156.7 million.
  • Neogen advanced its Petrifilm manufacturing transition, with validation completed on 100% of equipment and completion still targeted for November 2026.
  • Full-year revenue outlook increased to $857 million-$860 million, while adjusted EBITDA guidance was maintained at approximately $175 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neogen Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260409479304) on April 09, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment